[ad_1]
“The first interim data analyzes of the Sputnik V vaccine against covid-19 during the third phase of the trials showed an efficacy of 92%,” indicated the developer of the preparation and the Russian sovereign wealth fund.
According to the joint statement, this result was obtained in an investigation with more than 16,000 volunteers, 21 days after receiving the first dose of the vaccine, which is inoculated in two doses, or a placebo, points out the Efe agency.
The numbers presented by Fox Business are even larger, as the economics website points out that “the so-called phase 3 involves more than 41,000 volunteers in 29 Moscow clinics, and only 25% receive placebo (a harmless substance, which neither the one who applies it and the patient does not know that he is being inoculated) ”.
For its part, the statement from the manufacturing laboratory cited by Efe talks about how the effectiveness of the drug was evidenced: “In the statistical analysis, 20 confirmed cases of the disease (COVID-19) were included, by whose distribution (in the group that was vaccinated and in the one who received the placebo) it was established that the efficacy of the Sputnik V vaccine was 92% ”.
These are the side effects in some of the volunteers
“During the investigation, no unexpected side effects have been detected. In part of the vaccinated, transitory effects were observed, such as pain at the site of inoculation of the vaccine, flu symptoms with increased body temperature, weakness, fatigue and headache ”, adds the statement.
Observation of study participants will continue for another six months, after which the final results will be published, stressed the Gamaleya Center and the FIDR.
A “detailed” study is also being carried out on the safety of the vaccine and immunogenesis in older people.
Russia assures that the data published today will be published by the researchers of the Gamaleya Center in one of the main medical journals after an independent evaluation by expert epidemiologists.
The Russian Minister of Health, Mikhail Murashkin, stressed that the results of the Sputnik V clinical tests “show that it is an effective means to stop the spread of the coronavirus, prevent the disease, which is the best way to defeat the pandemic ”.
This trill records the news of the effectiveness of the Russian Sputnik V vaccine:
Data based on preliminary studies on 16,000 Sputnik V volunteers 👇https: //t.co/1KQQ0Sp7uV
– Nora Bär (@norabar) November 11, 2020
The director of the Gamaleya Center, Alexandr Gintsburg, pointed out that the publication of the preliminary results “opens the way to mass vaccination in Russia against covid-19 in the coming weeks.”
The director of the FIDR, Kirill Dimítriev, recalled that the Russian vaccine uses human adenovirus as a vector and not mono or mRNA adenovirus vectors, as Russia often highlights.
The US pharmaceutical Pfizer announced this week that its vaccine against covid-19 (which is manufactured in conjunction with the German BioNTech) is 90% effective, above what is required by US regulators, which promises a rapid emergency authorization for its release to the public.
The Russian vaccine has not been without criticismas it was announced before clinical trials were completed and its effectiveness was questioned by the scientific community. The following video from the Argentine chain El Nueve (the country where the announcement of this vaccine caused a stir) explains the myths and truths of this drug:
How Pfizer’s Coronavirus Vaccine Will Be Distributed
The British newspaper Independent publishes that once the Pfizer vaccine was approved in the United States, it would begin to be distributed throughout the country just 24 hours later.
The group of scientists, says the AFP agency, designed special boxes for shipping (40x40x56 cm), which will contain dry ice. Each box will have 975 bottles with capacity for five doses each, for a total of 4,875 doses.
Six trucks will leave Kalamazoo, Michigan, USA, every day to deliver doses to airlines such as Fedex, UPS and DHL, which will distribute them quickly: in a day or two in the United States and in three days in the rest of the world, Pfizer told the news agency. 20 daily cargo flights will distribute future doses across the planet.
Fedex told AFP that it obtained permission from the Federal Aviation Administration to transport more dry ice aboard its Boeing 767 and 777. Dry ice is solidified carbon dioxide, the sublimation of which (the transition from a solid to a gaseous state) could be dangerous for the crew.
See also: Pfizer vaccine: she is the Colombian who participates in its development
[ad_2]
